CLB FY 2007 Earnings Report — Core Laboratories N.V. Revenue & Financial Results | Market Cap Arena

Core Laboratories N.V.CLB

FY 2007 Earnings

Reported February 21, 2008

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2007	Prior Q	FY 2006	QoQ Change	YoY Change
Revenue	$671M	—	$576M	—	16.5%
Op. Income	$184M	—	$124M	—	48.8%
Gross Margin	33.0%	—	29.3%	—	3.7pp
Net Margin	18.1%	—	14.4%	—	3.7pp
EPS (Diluted)	$2.48	—	$1.54	—	61.0%
Free Cash Flow	$102M	—	$96M	—	6.2%

Revenue Flow

Item	Amount
REVENUE	$671M
Cost of Revenue	$449M
GROSS PROFIT	$221M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$34M
Other Expenses	$4M
Operating Expenses	$38M
Cost & Expenses	$487M
OPERATING INCOME	$184M
Interest Income	$0
Interest Expense	$0
Other Income/Expenses	-$3M
INCOME BEFORE TAX	$181M
Income Tax Expense	$60M
Net Income from Continuing Ops	$121M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$121M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$121M
D&A	$19M
EBIT	$184M
EBITDA	$203M
EPS	$3
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$671M
Cost of Revenue	$449M
GROSS PROFIT	$221M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$34M
Other Expenses	$4M
Operating Expenses	$38M
Cost & Expenses	$487M
OPERATING INCOME	$184M
Interest Income	$0
Interest Expense	$0
Other Income/Expenses	-$3M
INCOME BEFORE TAX	$181M
Income Tax Expense	$60M
Net Income from Continuing Ops	$121M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$121M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$121M
D&A	$19M
EBIT	$184M
EBITDA	$203M
EPS	$3
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$121M
Depreciation & Amortization	$19M
Stock-Based Compensation	$0
Deferred Income Tax	$6M
Other Non-Cash Items	-$4M
Change in Working Capital	-$17M
OPERATING CASH FLOW	$126M
Capital Expenditure	-$24M
Acquisitions (Net)	-$7M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$12M
NET CASH FROM INVESTING	-$20M
Net Debt Issuance	$263.0K
Common Stock Repurchased	-$182M
Common Dividends Paid	$0
Other Financing Activities	$29M
NET CASH FROM FINANCING	-$134M
FREE CASH FLOW	$102M
Net Change in Cash	-$29M

Balance Sheet

Item	Amount
Cash & Equivalents	$26M
Short-Term Investments	$0
Net Receivables	$108M
Inventory	$29M
Other Current Assets	$29M
TOTAL CURRENT ASSETS	$221M
PP&E (Net)	$93M
Goodwill	$139M
Intangible Assets	$7M
Long-Term Investments	$0
Tax Assets	$26M
Other Non-Current Assets	$19M
TOTAL NON-CURRENT ASSETS	$284M
TOTAL ASSETS	$505M
Account Payables	$40M
Short-Term Debt	$3M
Deferred Revenue	$9M
Other Current Liabilities	$9M
TOTAL CURRENT LIABILITIES	$98M
Long-Term Debt	$300M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$0
Other Non-Current Liabilities	$43M
TOTAL NON-CURRENT LIABILITIES	$343M
TOTAL LIABILITIES	$441M
Common Stock	$1M
Additional Paid-In Capital	$0
Retained Earnings	$62M
Treasury Stock	-$2M
Accum. Other Comp. Income	$226.0K
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$62M
Minority Interest	$1M
TOTAL EQUITY	$64M
TOTAL LIABILITIES & EQUITY	$505M
Total Debt	$303M
Net Debt	$277M